Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

Table S1 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases

<p>Read sequencing depth by sample</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	N. Ari Wijetunga (15056183) (author)
Diğer Yazarlar:	Alexander G. Goglia (15056186) (author), Nils Weinhold (15056189) (author), Michael F. Berger (15048171) (author), Michael Cislo (15056192) (author), Daniel S. Higginson (14949837) (author), Kiana Chabot (15056195) (author), Ahmed M. Osman (15056198) (author), Lauren Schaff (15056201) (author), Elena Pentsova (15056204) (author), Alexandra M. Miller (15056207) (author), Simon N. Powell (15056210) (author), Adrienne Boire (14944705) (author), Jonathan T. Yang (15056213) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Therapeutic Research and Development Methods and Technology CNS Cancers Gene Technologies High-throughput sequencing Liquid Biopsy Radiation Oncology Molecular targets of radiation response Translational Research
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Table S2 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
Yazar:: N. Ari Wijetunga (15056183)
Baskı/Yayın Bilgisi: (2025)

Table S3 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
Yazar:: N. Ari Wijetunga (15056183)
Baskı/Yayın Bilgisi: (2025)

Table S4 from Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases
Yazar:: N. Ari Wijetunga (15056183)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 2 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 3 from Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation
Yazar:: Francesca Orzan (15055579)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S1 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S2 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S3 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S4 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S5 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure S6 from Radiotherapy-Induced Neurocognitive Impairment Is Driven by Heightened Apoptotic Priming in Early Life and Prevented by Blocking BAX
Yazar:: Rumani Singh (17141575)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Yazar:: Mengjie Zhao (14845174)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Yazar:: Mengjie Zhao (14845174)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Yazar:: Mengjie Zhao (14845174)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S5 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Yazar:: Mengjie Zhao (14845174)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S8 from PGC1α Degradation Suppresses Mitochondrial Biogenesis to Confer Radiation Resistance in Glioma
Yazar:: Mengjie Zhao (14845174)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure 1 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
Yazar:: Amy C. Degnim (15106462)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure 2 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
Yazar:: Amy C. Degnim (15106462)
Baskı/Yayın Bilgisi: (2025)

Supplemental Figure 3 from Trimodality Therapy Improves Disease Control in Radiation-Associated Angiosarcoma of the Breast
Yazar:: Amy C. Degnim (15106462)
Baskı/Yayın Bilgisi: (2025)

Supplementary Appendix S1 from DNA-Methylome–Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy
Yazar:: Bouchra Tawk (15389486)
Baskı/Yayın Bilgisi: (2025)

Figure 1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 2 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 3 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 4 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Figure 5 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Small-Molecule Polθ Inhibitors Provide Safe and Effective Tumor Radiosensitization in Preclinical Models
Yazar:: Gonzalo Rodriguez-Berriguete (15056057)
Baskı/Yayın Bilgisi: (2025)

Immunohistochemical staining for PHLDA3, APOE, and CPE in irradiated brain tissues.
Yazar:: Jing Liu (38537)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
Yazar:: Naoshad Muhammad (14960127)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
Yazar:: Naoshad Muhammad (14960127)
Baskı/Yayın Bilgisi: (2025)

Global Wildfire Brown Carbon Simulation Results: Supporting Data for "Strong Shortwave Absorption by Wildfire Brown Carbon from Global Observations and Modeling"
Yazar:: Lulu Xu (21634004)
Baskı/Yayın Bilgisi: (2025)

2024 Meteorological Data, Upper Chesapeake Bay, MarineGEO, Smithsonian Environmental Research Center
Yazar:: Sam Benson (17684957)
Baskı/Yayın Bilgisi: (2025)

Supplementary Figure 1 from Randomized Phase II Study of Physiologic MRI-Directed Adaptive Radiation Boost in Poor Prognosis Head and Neck Cancer
Yazar:: Michelle L. Mierzwa (14963463)
Baskı/Yayın Bilgisi: (2025)

Supplementary Tables S1-S11 from <i>NBN</i> Pathogenic Germline Variants are Associated with Pan-Cancer Susceptibility and <i>In Vitro</i> DNA Damage Response Defects
Yazar:: Sami Belhadj (15052341)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Early Changes in Circulating Cell-Free <i>KRAS</i> G12C Predict Response to Adagrasib in KRAS Mutant Non–Small Cell Lung Cancer Patients
Yazar:: Cloud P. Paweletz (14960112)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data 1 from Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer
Yazar:: Whitney L. Hensing (16461978)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Yazar:: Stephanie Lheureux (16797697)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Yazar:: Stephanie Lheureux (16797697)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Yazar:: Stephanie Lheureux (16797697)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression
Yazar:: Stephanie Lheureux (16797697)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_fb5rfrtggmruafoj62kjbd24fo